Gilead Sciences Reports Q2 2026 Financial Results

What Happened
Gilead Sciences, Inc. announced its financial results for the quarter ended June 30, 2026 in an 8‑K filed August 4, 2026 and furnished a press release as Exhibit 99.1. The company presented results on both a GAAP and non‑GAAP basis and stated that management uses non‑GAAP measures internally for operating, budgeting and planning purposes. A reconciliation between GAAP and non‑GAAP figures is provided in the press release (pages 10–13).

Key Details

• Filed/furnished: 8‑K dated August 4, 2026, reporting results for the quarter ended June 30, 2026.
• Press release: Exhibit 99.1 attached to the 8‑K; reconciliation of GAAP to non‑GAAP on pages 10–13.
• Accounting presentation: Results shown on both GAAP and non‑GAAP bases; company cautions non‑GAAP is supplemental and may differ from peers.
• Legal note: The furnished materials are not deemed “filed” for purposes of Section 18 of the Exchange Act and are not incorporated by reference into other filings.

Why It Matters
Investors should review the furnished press release and the GAAP/non‑GAAP reconciliation to understand Gilead’s reported earnings, revenue trends and the adjustments management used to present operating performance. Because non‑GAAP measures can exclude items that affect cash flow or future results, comparing both GAAP and non‑GAAP figures is important for an accurate view of quarterly results and for comparing Gilead to peers.